Longitudinally extensive transverse myelitis after Covid-19 vaccination: case report and review of literature
Seyed Farzad Maroufi, Fereshteh Naderi Behdani, Fatemeh Rezania, Samaneh Tanhapour Khotbehsara, Zahra Mirzaasgari
Abstract
Mass vaccination has been the main policy to overcome the Covid-19 pandemic. Several vaccines have been approved by the World Health Organization. With growing vaccination, safety concerns and adverse events that need prompt evaluation are also emerging. Herein, we report a case of a healthy woman with longitudinally extensive transverse myelitis after vaccination with the AstraZeneca vaccine. The patient was successfully treated after ruling out all the possible causes.
Topics & Concepts
Transverse myelitisVaccinationMedicineCoronavirus disease 2019 (COVID-19)PandemicMyelitisAdverse effect2019-20 coronavirus outbreakPediatricsVirologyIntensive care medicineImmunologyMultiple sclerosisPathologyInternal medicineDiseaseSpinal cordPsychiatryOutbreakInfectious disease (medical specialty)Peripheral Neuropathies and DisordersMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 Research